l -Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Objective The authors conducted two multicenter sequential parallel comparison design trials to investigate the effect of L-methylfolate augmentation in the treatment of major depressive disorder in patients who had a partial response or no response to selective serotonin reuptake inhibitors (SSRIs). Method In the first trial, 148 outpatients with SSRI-resistant major depressive disorder were enrolled in a 60-day study divided into two 30-day periods. Patients were randomly assigned, in a 2:3:3 ratio, to receive L-methylfolate for 60 days (7.5 mg/day for 30 days followed by 15 mg/day for 30 days), placebo for 30 days followed by L-methylfolate (7.5 mg/day) for 30 days, or placebo for 60 days. SSRI dosages were kept constant throughout the study. In the second trial, with 75 patients, the design was identical to the first, except that the l-methylfolate dosage was 15 mg/day during both 30-day periods. Results In the first trial, no significant difference was observed in outcomes between the treatment groups. In the second trial, adjunctive L-methylfolate at 15 mg/day showed significantly greater efficacy compared with continued SSRI therapy plus placebo on both primary outcome measures (response rate and degree of change in depression symptom score) and two secondary outcome measures of symptom severity. The number needed to treat for response was approximately six in favor of adjunctive L-methylfolate at 15 mg/day. L-Methylfolate was well tolerated, with rates of adverse even…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Folate has been studied in a placebo-controlled trial an adjunctive treatment to fluoxetine, with significantly greater improvement in the folate group, a difference most pronounced in women [43].”
From Complementary and alternative medicine therapies for perinatal depression (2014) · cites this paper as [43]
In the citing paper
“94% of women who received fluoxetine with the addition of folate 500 mcg per day were treatment responders, compared to 61% of those who received fluoxetine and placebo.”
From Complementary and alternative medicine therapies for perinatal depression (2014) · cites this paper as [43]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
ECDEU Assessment Manual: (591322011-001)
Guy, W. (1976) · PsycEXTRA Dataset · doi:10.1037/e591322011-001 · Cited by 1,896
TRIVEDI, M. H., RUSH, A. J., IBRAHIM, H. M., CARMODY, T. J., BIGGS, M. M., SUPPES, T., CRISMON, M. L., SHORES-WILSON, K., TOPRAC, M. G., DENNEHY, E. B., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291703001107 · Cited by 968
Nelson, J. C., & Papakostas, G. I. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030312 · Cited by 552
Self-citationFava, M., Evins, A. E., Dorer, D. J., & Schoenfeld, D. A. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000069738 · Cited by 452
Self-citationEnhancement of recovery from psychiatric illness by methylfolate
Godfrey, P. S. A., Toone, B. K., Bottiglien, T., Laundy, M., Reynolds, E. H., Carney, M. W. P., Flynn, T. G., & Chanarin, I. (1990) · The Lancet · doi:10.1016/0140-6736(90)91942-4 · Cited by 389
Coppen, A., & Bailey, J. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00153-1 · Cited by 337
Lithium Augmentation in Treatment-Resistant Depression: Meta-Analysis of Placebo-Controlled Studies
Bauer, M., & Döpfmer, S. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910000-00006 · Cited by 304
Papakostas, G. I., Mischoulon, D., Shyu, I., Alpert, J. E., & Fava, M. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09081198 · Cited by 297
Self-citationFolate, vitamin B12, and homocysteine in major depressive disorder
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.3.426 · Cited by 287
Self-citationCoppen, A., American Psychological Association, & Bailey, J. (2000) · PsycEXTRA Dataset · doi:10.1037/e323122004-002 · Cited by 236
The neuropsychiatry of megaloblastic anaemia.
Shorvon, S. D., Carney, M. W., Chanarin, I., & Reynolds, E. H. (1980) · BMJ · doi:10.1136/bmj.281.6247.1036 · Cited by 218
Emergence of Adverse Events Following Discontinuation of Treatment With Extended-Release Venlafaxine
Fava, M., Mulroy, R., Alpert, J., Nierenberg, A. A., & Rosenbaum, J. F. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.12.1760 · Cited by 198
Self-citationFolate Deficiency in Depressive Illness
Reynolds, E. H., Preece, J. M., Bailey, J., & Coppen, A. (1970) · British Journal of Psychiatry · doi:10.1192/s0007125000193250 · Cited by 183
Folic acid enhances lithium prophylaxis.
Coppen, A., Chaudhry, S., & Swade, C. (1986) · Journal of Affective Disorders · doi:10.1016/0165-0327(86)90043-1 · Cited by 164
Serum folate values in 423 psychiatric patients.
Carney, M. W. (1967) · BMJ · doi:10.1136/bmj.4.5578.512 · Cited by 154
Fava, M., Mischoulon, D., Iosifescu, D., Witte, J., Pencina, M., Flynn, M., Harper, L., Levy, M., Rickels, K., & Pollack, M. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000332050 · Cited by 141
Self-citationFolate deficiency, biopterin and monoamine metabolism in depression
Bottiglieri, T., Hyland, K., Laundy, M., Godfrey, P., Carney, M. W. P., Toone, B. K., & Reynolds, E. H. (1992) · Psychological Medicine · doi:10.1017/s0033291700038447 · Cited by 136
Self-citationFolinic Acid (Leucovorin) as an Adjunctive Treatment for SSRI-Refractory Depression
Alpert, J. E., Mischoulon, D., Rubenstein, G., Bottonari, K. A., Nierenberg, A. A., & Fava, M. (2002) · Annals of Clinical Psychiatry · doi:10.1023/a:1015271927517 · Cited by 134
Self-citationPapakostas, G. I., Petersen, T., Mischoulon, D., Ryan, J. L., Nierenberg, A. A., Bottiglieri, T., Rosenbaum, J. F., Alpert, J. E., & Fava, M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0810 · Cited by 113
Self-citationAlpert, J. E., Papakostas, G., Mischoulon, D., Worthington, J. J., Petersen, T., Mahal, Y., Burns, A., Bottiglieri, T., Nierenberg, A. A., & Fava, M. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000145339.45794.cd · Cited by 105
Self-citationPapakostas, G. I., Petersen, T., Lebowitz, B. D., Mischoulon, D., Ryan, J. L., Nierenberg, A. A., Bottiglieri, T., Alpert, J. E., Rosenbaum, J. F., & Fava, M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005195 · Cited by 101
Self-citationEnhancement of recovery from psychiatric illness by methylfolate
Godfrey, P., Crellin, R., Toone, B. K., Flynn, T. G., Carney, M. W. P., Laundy, M., Chanarin, I., Bottiglieri, T., & Reynolds, E. H. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.161.1.126 · Cited by 99
Self-citationSerum and red blood cell folate in depression
Abou‐Saleh, M. T., & Coppen, A. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb01303.x · Cited by 95
Chen, Y., Yang, Y., Hung, H., & Wang, S. (2011) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.04.006 · Cited by 86
An Open Trial of Methyltetrahydrofolate in Elderly Depressed Patients
Guaraldi, G. P., Fava, M., Mazzi, F., & la Greca, P. (1993) · Annals of Clinical Psychiatry · doi:10.3109/10401239309148970 · Cited by 81
An examination of the efficiency of the sequential parallel design in psychiatric clinical trials
Tamura, R. N., & Huang, X. (2007) · Clinical Trials · doi:10.1177/1740774507081217 · Cited by 73
Alpert, M., Silva, R. R., & Pouget, E. R. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084024.22282.cd · Cited by 72
Papakostas, G. I., Petersen, T., Mischoulon, D., Green, C. H., Nierenberg, A. A., Bottiglieri, T., Rosenbaum, J. F., Alpert, J. E., & Fava, M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0811 · Cited by 72
Self-citationFolic acid deficiency and depression
GHADIRIAN, A. M., Ananth, J., & Engelsmann, F. F. (1980) · Psychosomatics · doi:10.1016/s0033-3182(80)73586-7 · Cited by 72
Antiepileptic Therapy, Folate Deficiency, and Psychiatric Morbidity: A General Practice Survey
Edeh, J., & Toone, B. (1985) · Epilepsia · doi:10.1111/j.1528-1157.1985.tb05676.x · Cited by 68
Change in folate status with antidepressant treatment
Wesson, V. A., LEVITT, A. J., & Joffe, R. T. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90058-2 · Cited by 51
Papakostas, G. I., Iosifescu, D. V., Renshaw, P. F., Lyoo, I. K., Lee, H. K., Alpert, J. E., Nierenberg, A. A., & Fava, M. (2005) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2005.09.001 · Cited by 49
Self-citationWilkinson, A. M., Anderson, D., Abou‐Saleh, M. T., WESSON, M. L., Blair, J. A., Farrar, G., & Leeming, R. J. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90014-0 · Cited by 16
Research works printed but not linked: 3
- 10.3109/10401230209147396 · doi:10.3109/10401230209147396 · Paper page
- Passeri M, 1993, Aging (Milano), 5, 63
- First MB, 1995, Structured Clinical Interview for DSM-IV Axis I Disorders With Psychotic Screen (SCID-I/P w/ Psychotic Screen) Version 2.0
Cited by
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
B Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review
Kennedy, D. (2016) · Nutrients · doi:10.3390/nu8020068 · Cited by 1,055
“This mechanism would accommodate the observation that folate increases endothelial vasodilation via a mechanism entirely unrelated to homocysteine [57,79] and would accommodate epidemiological observations of a relationship between reduced folate status and depression and disturbed cognitive function [56,78,80].”
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
“5 mg/day was ineffective (Papakostas et al., 2012).”
Neuroinflammation and psychiatric illness
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733
“Animal data showed that SSRIs could restore deficient endothelial NO levels [219], suggesting that anti-oxidative mechanisms may contribute to their antidepressant effects.”
InfluentialDaly, E. J., Singh, J. B., Fedgchin, M., Cooper, K., Lim, P., Shelton, R. C., Thase, M. E., Winokur, A., Van Nueten, L., Manji, H., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3739 · Cited by 718
Self-citation
Metadata
- Authors
- Papakostas, G. I., Shelton, R. C., Zajecka, J. M., Etemad, B., Rickels, K., Clain, A., Baer, L., Dalton, E. D., Sacco, G. R., Schoenfeld, D., Pencina, M., Meisner, A., Bottiglieri, T., Nelson, E., Mischoulon, D., Alpert, J. E., Barbee, J. G., Zisook, S., & Fava, M.
- Affiliations
- Boston University (US)
- From the Center for Treatment-Resistant Depression, Depression Clinical and Research Program, the Biostatistics Center, and the Clinical Trials Network and Institute, Massachusetts General Hospital, Boston; Harvard Medical School, Boston; the Harvard Clinical Research Institute, Boston; the Department of Biostatistics, Boston University, Boston; the Department of Psychiatry, Vanderbilt University School of Medicine, Nashville; Rush University Medical Center, Chicago; the Department of Psychiatry,...
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2012-12
- Volume
- 169
- Issue
- 12
- Pages
- 1267-1274
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2136722242
- Cited by
- 275
- References
- 36
- Citations by year
- 2026: 21 · 2025: 8 · 2024: 12 · 2023: 11 · 2022: 14 · 2021: 20 · 2020: 18 · 2019: 22 · 2018: 27 · 2017: 19 · 2016: 26 · 2015: 26 · 2014: 25 · 2013: 25 · 2012: 1
- FWCI
- 18.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- 5-methyltetrahydrofolate, major depressive disorder, selective serotonin reuptake inhibitors, adjunctive therapy, treatment-resistant depression, antidepressant augmentation, response rate, adverse events, folic acid supplementation
- MeSH terms
- Major Depressive Disorder, Depressive Disorder, Major, Dose-Response Relationship, Drug, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Tetrahydrofolates, Treatment Outcome, Chemotherapy, Adjuvant, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.